1.泡泡玛特：预计上半年溢利同比录得增长不低于350% 据财联社，泡泡玛特公告，预期本集团截至2025年6月30日止六个月之收入可能较截至2024年6月30日止六 个月之收入增长不低于200%；预期本期间本集团溢利（不包括未完成统计的金融工具的公允价值变动损 益）较本集团去年同期溢利可能增长不低于350%。 2.罗马仕：公司运营团队主要成员在岗，本次召回长期有效 7月15日，罗马仕发布声明称，近日关注到网络上关于罗马仕的大量不实信息。公司从未停止履行承诺，产 品召回及售后服务系统按计划持续运转。为了更长远的未来，面对此次运营挑战，罗马仕进行了战略调 整，公司运营团队主要成员在岗，将所有可用资源优先投入到用户权益保障中。公司承诺本次召回服务长 期有效，绝不因时间或地域差异影响服务品质。 3.马斯克推出二次元"AI女友"，30美元/月 作为一个令业界感到震惊的转变，世界首富埃隆·马斯克的AI聊天机器人Grok短短几天内从口无遮拦惹出大 祸的麻烦精，变成具有可爱形象且能实时互动的二次元女孩。目前这项服务仅向每月支付30美元的 SuperGrok订阅服务用户开放。 点评：虚拟情感变现，马斯克再掀AI消费新浪潮。 4. ...

近日，有媒体报道称，京东健康旗下首个线下医美自营诊所"京东医美（亦庄店）"在北京亦庄开业，接 入京东医美频道。对此，京东医美向南都记者回应称，京东健康体检中心（亦庄店）医疗美容科的服务 项目上线京东App，用户可搜索"京东医美"进行服务查询或预约，"作为京东健康体检中心的特色专科 之一，医疗美容科致力于为用户提供安全有效、价格透明、不推销的轻医美服务，工作日营业时间延迟 至22点，打造'上班族友好型'的专业医美科室。" （文章来源：南方都市报） 去年9月，美团披露医美相关数据，当年新开医美机构近3000家，同比增长38.5%。美团调研数据显 示，约73%的消费者将线上作为主要购买渠道。近一年，无创抗衰、水光补水、注射塑形的线上交易年 增速超过110%，近84%的医美需求集中在维养与抗衰类项目。 根据国家医保局数据，据不完全统计，2024年我国美容整形市场规模近3000亿元。盯上这个千亿市场的 也不仅有美团和京东，在淘宝、抖音等平台均可以参与医美产品的团购。 南都记者在京东App查询发现，京东医美（亦庄店）目前提供美白嫩肤、水光美塑、光电抗衰以及除皱 瘦脸的服务，包括瘦脸针、水光针、激光脱毛等。从价格来看，仅有 ...

2025.07. 16 据上海证券报，继外卖、酒旅、短剧之后，如今，京东又入局了医美赛道。 近日，京东健康旗下的首个线下医美自营诊所在北京亦庄开业。这是京东健康旗下首个自营线下医美 诊所，目前命名为"京东医美（亦庄店）"。据悉，这是继今年3月京东健康设立医美子公司后，线下 门店的首度公开亮相。京东健康的第二家线下自营美诊所北京"国贸店"将在9月30日开业。 爱企查App显示，北京京东叁佰陆拾度电子商务有限公司已申请注册多枚"京东医美"商标，国际分类 涉及广告销售、医疗园艺、科学仪器等，目前上述商标状态多为等待实质审查。 微信编辑 | 苏小 推荐阅读 三小时搬800箱，一台机器人或可替代约1.4~2名工人！实探智元机器人落地工厂 目前，京东医美（亦庄店）并未单独设立独立区域，而是选址于京东健康综合门诊部（亦庄店）的一 楼，其服务范围涵盖美白嫩肤、水光美塑、除皱瘦脸以及光电抗衰四大热门轻医美项目。 记者打开京东App发现，该诊所的线上访问端口直接整合于该App之内，用户只需在App内搜索"医 美"这一关键词，即可跳转至京东医美专属频道，进而通过该频道进入京东医美自营官方旗舰店。此 外，京东医美现已上线微信小程序。 ...

以下文章来源于信风TradeWind ，作者郑敏芳 信风TradeWind . 关注资本市场的趋势与发展 作者郑敏芳 编辑松壑 医美生意正在被更多互联网大厂觊觎。 7月14日，信风注意到京东健康（6618.HK）旗下的首个线下医美自营诊所低调在北京亦庄开业。 这是京东健康旗下首个自营线下医美诊所，目前命名为"京东医美（亦庄店）"，并接入了京东APP的医美频道。 这是继今年3月京东健康设立医美子公司后，线下门店的首度公开亮相。 信风了解到，京东健康的第二家线下自营美诊所北京"国贸店"将在9月30日开业。 这是继外卖之后，京东与美团再度在医美业务领域展开竞争。 不过二者的运营模式仍有较大的差异，美团聚焦于充当平台的角色，并未涉足自营。 平台企业与医美机构争夺线下实体渠道，正在变成医美行业的重要发展趋势。例如新氧（SY.O）亦布局了数十家线下医美机构。 随着互联网巨头的加入，下游医美机构的客源争夺正变得更加激烈。 早在3个多月前，京东健康就设立了子公司北京京东医疗美容诊所有限公司，并申请了"京东医美"的商标。 刘强东今年6月表态，餐饮、酒店的供应链之后，京东未来还会有美容、医美、医院等场景的供应链。 如今，京东健康 ...

但从其过往历程来看，京东在医美领域落子已久。2021年9月，京东健康与新氧合作共建的医美频道正 式上线，引入超2000家认证机构，主要为用户提供线上问诊、方案定制等服务。 2023年，京东健康又与艾尔建、华熙生物等上游厂商达成直供合作，产品覆盖鼻部整形、皮肤美容等超 万个SKU。今年3月，京东健康又设立子公司北京京东医疗美容诊所有限公司，经营范围包括医疗服 务、医疗美容服务、生活美容服务等，并申请了"京东医美"商标。 7月14日，京东健康旗下的医美自营诊所正式宣布对外营业，名为"京东医美（亦庄店）"，这是京东线 下医美门店首次公开亮相。目前，已接入京东APP的医美频道。 据悉，该店位于京东健康综合门诊部（亦庄店）1层，主要提供美白嫩肤、水光美塑、除皱瘦脸和光电 抗衰四大轻医美服务。实际上，京东医美（亦庄店）已试营业两个多月，此前主要面向京东内部员工开 放。有报道称，京东医美还计划于9月或者10月在北京国贸万通中心开设第二家自营旗舰店。 与进军外卖、酒旅不同的是，京东此次进入医美行业较为低调，并未推出大规模补贴政策。 在6月份的分享会上，刘强东也曾透露，京东每三年就应该扩张一次，不仅要做餐饮、酒店，未来还会 有 ...

Summary of Conference Call Company and Industry - The conference call primarily discusses a company involved in the healthcare and pharmaceutical industry, focusing on products related to weight loss and hair restoration. Key Points and Arguments Compliance and Market Challenges - The compliance products have seen a slight increase in market share, now accounting for approximately 20-30% of the total market, indicating a shift towards more regulated products [1] - Institutions using non-compliant products face significant penalties if caught, creating a dilemma between using compliant products with potential negative feedback and non-compliant products with regulatory risks [2] Product Launch and Market Positioning - The company is preparing to launch its first compliant product in the weight loss sector, aiming to capture market share quickly due to the first-mover advantage [3] - The company has identified a gap in the market for localized fat reduction products, differentiating itself from competitors focused on overall weight loss solutions [4] Product Efficacy and Safety - The new product, a recombinant collagenase, is designed to minimize pain during use, with reported pain duration significantly lower than competitors, lasting only 2,000-3,000 units compared to over 7,000 for others [5][6] - Clinical trials show over 50% fat reduction in participants after one month and over 80% after three months, with a single injection providing lasting effects [7] Development Strategy - The company has a clear three-tier development strategy, focusing first on generating revenue from existing products, followed by the introduction of new drugs in the coming years [8][9] - The company aims to achieve over 100 million RMB in revenue from its flagship product within the first year of commercialization, which is considered a conservative estimate [31] Market Trends and Consumer Behavior - The hair restoration market is experiencing rapid growth, with a projected increase to over 50 billion RMB by 2025, driven by rising consumer anxiety and stress-related hair loss [18] - Oral finasteride currently holds a significant market share but has side effects that the company's topical product aims to mitigate, offering similar efficacy without systemic side effects [19][20] Pricing Strategy - The pricing for the new products is expected to be competitive with international standards, with the topical finasteride priced around 1,400 RMB per bottle, which is lower than its overseas counterparts [24] - The company plans to maintain a balance between affordability and quality, ensuring that the products are accessible to a broad consumer base [25] Distribution and Marketing - The company has made significant progress in establishing distribution channels, with hundreds of medical institutions and pharmacies already onboarded prior to product launch [29] - Marketing efforts are being ramped up, with a focus on online promotions and influencer partnerships to maximize product visibility [15][28] Financial Performance - The company reported strong internal sales growth, with expectations for continued performance improvement as new products are launched [13] - Cost management strategies have been implemented, resulting in a decrease in absolute expenses while maintaining revenue growth [16] Future Outlook - The company is optimistic about its growth trajectory, with plans to expand its product line and enhance its market presence in the coming years [40] - There is a strong belief in the long-term potential of the brand, aiming for it to reach a scale of 1 billion RMB in revenue [40] Other Important Content - The company emphasizes the importance of safety and efficacy in its product offerings, particularly in the context of increasing consumer awareness and regulatory scrutiny [27] - The management team has a history of adapting quickly to market changes, which is seen as a critical factor in their ongoing success [36]

当下，中国医美市场正以前所未有的速度扩张，艾瑞咨询数据显示，2021年规模已达2179亿元，预计 2030年将突破万亿大关。 互联网巨头看好颜值经济 颜值经济吸引互联网巨头纷纷入局。例如，阿里通过天猫国际引入国际医美设备品牌，支付宝推出"医 美分期+效果保险"组合产品，口碑联合头部机构打造"安心美"联盟，复购率提升至65%。美团2024年医 美类目GMV突破380亿元，新一线城市贡献率达47%，并测试AI智能推荐系统，通过18个维度数据为用 户定制方案。 此外，字节跳动的抖音医美科普专区日均播放量达2.3亿次，巨量引擎推出"品效合一"营销方案，帮助 机构获客成本降至行业平均水平的60%；拼多多以"百亿补贴"拉低热玛吉等项目价格40%，创新"拼团美 疗"模式，单月参与人次突破80万。 京东加入"战局" 近日，京东健康旗下的首个线下医美自营诊所在北京亦庄开业，位于京东健康综合门诊部（亦庄店）1 层。据介绍，这是京东健康旗下首个自营线下医美诊所，目前命名为"京东医美(亦庄店)"，并接入了京 东App的医美频道。一位京东医美医生助理表示，京东第二家线下自营医美诊所北京"国贸店"最快9月 或10月开业。 目前，京东医美 ...

Group 1: Nvidia and Market Impact - Nvidia announced the resumption of H20 sales in China and the launch of a new fully compatible GPU for the Chinese market, leading to a 4.04% increase in its stock price, adding approximately $161.8 billion to its market capitalization, which now stands at about $4.17 trillion [2] Group 2: Apple and Supply Chain Changes - Apple has decided to abandon its self-developed foldable iPhone in favor of a solution from Samsung Display, indicating a deeper collaboration with Samsung's supply chain [3] Group 3: Meta and Regulatory Challenges - Meta faces new antitrust challenges from the EU, having been fined €200 million for unresolved issues related to its "pay or consent" advertising model [4] Group 4: Autonomous Driving Partnerships - Baidu's "萝卜快跑" announced a strategic partnership with Uber to integrate thousands of autonomous vehicles into Uber's global network, with initial deployments planned for Asia and the Middle East [6] - BMW partnered with Momenta to develop a new generation of intelligent driving assistance solutions tailored for the Chinese market, leveraging AI models [8] Group 5: Robotics Industry Growth - The robotics industry is experiencing rapid growth, with significant increases in shipments noted by Yu Shu Technology's CEO, who anticipates accelerated application in the next 3-5 years [7] Group 6: Electric Vehicle Incentives - Various provinces are offering cash subsidies for purchasing specific models of 鸿蒙智行 vehicles, with subsidies ranging from 3,000 yuan per vehicle to 20,000 yuan for certain models [9] Group 7: JD Health's Entry into Medical Aesthetics - JD Health opened its first self-operated offline medical aesthetics clinic in Beijing, marking its entry into the medical aesthetics sector [10] Group 8: Geely's Acquisition of Zeekr - Geely announced the privatization of Zeekr, signing an agreement to acquire all outstanding shares, with a premium over the previously announced acquisition price [11] Group 9: Charging Standards Update - New national standards for power banks are being developed to enhance safety and performance, including stricter testing requirements and monitoring functions [13] Group 10: Corporate Leadership Changes - Wentech Technology announced the resignation of its chairman and several board members as the company shifts its focus to the semiconductor business [14] Group 11: Innoscience's Capacity Expansion - Innoscience plans to significantly increase its wafer production capacity over the next five years, aiming to expand from 13,000 to 20,000 wafers per month by the end of 2025 [15] Group 12: Xiaopeng's Funding for Flying Cars - Xiaopeng Huaitian completed a $250 million Series B funding round to support the development and commercialization of flying cars, with plans for a production facility to be completed by Q4 this year [16] Group 13: Investment in Robotics - Zhiyuan Robotics received strategic investment from Charoen Pokphand Group to explore business opportunities in various verticals, enhancing its market position [17] Group 14: Bertley’s Investment Plans - Bertley announced plans to invest 198 million yuan in a partnership to target high-growth sectors, including humanoid robots and automotive intelligence [17]

短期出现震荡，但中期方向没有变化。周二 A 股盘中出现明显震荡，上证指数一度跌破 3500 点整 数关，但午盘开始震荡回升，收盘依然站在 3500 点上方。由于上证指数已经正式突破 2024 年 11 月 8 日的高点，因此判断自 2024 年四季度以来的横盘震荡已经告一段落，短期震荡对中期方向不会产生影 响。近期市场对于贸易冲突的担忧情绪进一步缓解， 7 月政策窗口期愈来愈近，预计市场将在震荡中继 续维持缓慢盘升的格局。 风险提示：全球地缘格局出现超预期局面，关税预期的反复摇摆，关税冲击的后续影响，美联储降 息延后，海外经济衰退超预期，国内经济复苏不及预期，政策执行不及预期等 后市展望：3500 点后的两种路径判断，突破前震荡蓄势概率较大。在指数突破 3500 点之后，市场 未来的路径有两种可能：1）继续延续上升趋势，直接挑战 2024 年 10 月 8 日的高点； 2）在挑战 3674 高点之前震荡蓄势，消化前期的套牢盘。行情一蹴而就挑战前高需要满足三个条件：1）财政加码政策 开始落地；2）全球环境继续缓和；3）成交量能持续有效放大。在三个条件没有形成共振之前，市场预 计将进行震荡蓄势，待时机成熟后挑战 ...

央视网消息：正值暑假，不少医美整形机构又迎来了整容的热潮。医生介绍，近年来整容低龄化趋势愈加明显，以前是准大学生想趁暑假"悄 悄变美"，现在越来越多的准高中生也加入了整容行列，前来咨询的求美者最小的只有11岁，而且这些未成年人咨询的整容项目也是五花八 门。 最小求美者11岁 咨询项目五花八门 记者在中国医学科学院整形外科医院了解到，最近这段时间，医院的整形手术预约量已经出现翻倍增长，不少家长带着刚刚考完试的孩子前来 咨询整容项目。 按照规定，未满18岁的青少年咨询整形美容项目，必须有父母陪同，然而一些不正规的医疗整形美容机构，打出"整形手术早做早变美"的旗 号，吸引未成年人前来整容，甚至帮助他们窜改病历，伪造年龄，逃避家长监护，导致一些青少年过早进行了整容手术。 越早做恢复越自然？未成年人整容风险大 对于整容美容手术，不少人认为越早做恢复越自然，真的是这样吗？专家提醒，未成年人整形存在极大风险。 医生介绍，未成年人面部骨骼、肌肉和软组织发育还不完全，如果这时候对面部骨骼进行改变，附着在上面的肌肉和脂肪垫都会发生相应改 变，从而影响正常的软组织发育，造成面部比例失调。 中国医学科学院整形外科医院主任医师 韩雪峰 ...